vTv Therapeutics Inc (VTVT) Stock Price

35.41 ▲ +1.26 (+3.69%)
Open: 33.68 Vol: 32.7K Day's range: 32.20 - 36.20 Jan 30, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VTVT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 35.79▲ 35.69▲ 35.48▲ 34.29▲ 36.06▼
MA10 35.62▲ 35.40▲ 35.08▲ 33.99▲ 34.29▲
MA20 35.63▲ 35.03▲ 34.60▲ 36.59▼ 29.14▲
MA50 35.26▲ 34.55▲ 34.67▲ 34.04▲ 22.04▲
MA100 34.70▲ 35.69▲ 37.34▼ 28.49▲ 20.01▲
MA200 35.53▲ 37.42▼ 36.14▼ 22.90▲ 23.57▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.012▲ 0.094▲ 0.228▲ -0.419▼ 0.398▲
RSI 60.433▲ 65.868▲ 60.554▲ 50.782▲ 64.708▲
STOCH 67.896     84.688▲ 86.874▲ 31.667     70.117    
WILL %R -28.436     -13.761▲ -11.050▲ -64.433     -35.496    
CCI 92.164     116.756▲ 134.759▲ -20.633     38.810    
Latest Filters Detected On VTVT
▲ RSI&VOL $VTVT RSI Cross Up and Volume Set Alert
RSI $VTVT RSI(14) Crossed Above 50 Set Alert
MA $VTVT Price Crossed Above MA(13) Set Alert
vTv Therapeutics Inc News
vTv Therapeutics (VTVT) Price Target Increased by 16.19% to 48.20
Wednesday, January 14, 2026 09:29 AM
The average one-year price target for vTv Therapeutics (NasdaqCM:VTVT) has been revised to $48.20 / share. This is an increase of 16.19% from the prior estimate of $41.48 dated December 18, 2025. The ...
TD Cowen Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation
Saturday, December 20, 2025 04:00 PM
Fintel reports that on January 5, 2026, TD Cowen initiated coverage of vTv Therapeutics (NasdaqCM:VTVT) with a Buy recommendation. As of December 21, 2025, the average one-year price target for vTv ...
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Thursday, December 18, 2025 08:05 AM
HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in ...
VTVT historical stock data
date open high low close volume
30/01/26 33.68 36.20 32.20 35.41 32,700
29/01/26 33.12 34.77 33.00 34.15 7,453
28/01/26 33.19 34.04 33.19 34.04 2,828
27/01/26 34.44 35.26 34.01 34.01 5,686
26/01/26 33.81 33.86 32.50 33.86 10,489
23/01/26 34.38 37.00 34.11 34.11 12,463
22/01/26 33.35 34.1721 33.35 33.54 7,061
21/01/26 32.20 34.09 32.20 33.05 5,800
20/01/26 35.19 35.19 31.80 32.10 20,129
16/01/26 38.49 39.7114 35.59 35.59 17,726
Quote Details
52wk Low:14.00
52wk High:44.00
Vol:32.7K
Avg Vol(3m):296K
1Y Chng:+63.14%
1M Chng:+2.91%
Add to Watch List
More Information
Index US Composite
Market Cap. 134.88M